117 related articles for article (PubMed ID: 3178248)
21. [Pemphigus vulgaris--malignant course].
Steiner A; Diem E
Hautarzt; 1986 Sep; 37(9):499-502. PubMed ID: 3533847
[TBL] [Abstract][Full Text] [Related]
22. Dapsone as initial treatment in superficial pemphigus. Report of nine cases.
Basset N; Guillot B; Michel B; Meynadier J; Guilhou JJ
Arch Dermatol; 1987 Jun; 123(6):783-5. PubMed ID: 3579359
[TBL] [Abstract][Full Text] [Related]
23. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study].
Morel P; Guillaume JC
Ann Dermatol Venereol; 1984; 111(10):925-8. PubMed ID: 6395773
[TBL] [Abstract][Full Text] [Related]
25. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
26. [Plasmapheresis in the treatment of pemphigus].
Blaszczyk M; Chorzelski T; Daszynski J; Jabłońska S; Beutner EH
Z Hautkr; 1985 Aug; 60(15):1175-82. PubMed ID: 4049988
[TBL] [Abstract][Full Text] [Related]
27. [Plasma exchange therapy of pemphigus vulgaris].
Ikeda S; Yamada H; Takamori K; Ogawa H
Nihon Rinsho; 1992 Jan; 50 Suppl():417-22. PubMed ID: 1578716
[No Abstract] [Full Text] [Related]
28. Outcome of pemphigus vulgaris.
Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
[TBL] [Abstract][Full Text] [Related]
29. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.
Hato N; Yamada H; Kohno H; Matsumoto S; Honda N; Gyo K; Fukuda S; Furuta Y; Ohtani F; Aizawa H; Aoyagi M; Inamura H; Nakashima T; Nakata S; Murakami S; Kiguchi J; Yamano K; Takeda T; Hamada M; Yamakawa K
Otol Neurotol; 2007 Apr; 28(3):408-13. PubMed ID: 17414047
[TBL] [Abstract][Full Text] [Related]
30. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Heaphy MR; Albrecht J; Werth VP
Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
[TBL] [Abstract][Full Text] [Related]
31. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
Mintz PD; Neff A; MacKenzie M; Goodnough LT; Hillyer C; Kessler C; McCrae K; Menitove JE; Skikne BS; Damon L; Lopez-Plaza I; Rouault C; Crookston KP; Benjamin RJ; George J; Lin JS; Corash L; Conlan MG
Transfusion; 2006 Oct; 46(10):1693-704. PubMed ID: 17002625
[TBL] [Abstract][Full Text] [Related]
32. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.
Glöckner WM; Sieberth HG; Wichmann HE; Backes E; Bambauer R; Boesken WH; Bohle A; Daul A; Graben N; Keller F
Clin Nephrol; 1988 Jan; 29(1):1-8. PubMed ID: 3289804
[TBL] [Abstract][Full Text] [Related]
33. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
[TBL] [Abstract][Full Text] [Related]
34. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus.
Aoyama Y; Tsujimura Y; Funabashi M; Sato M; Kamiya H; Kitajima Y
Eur J Dermatol; 2000; 10(1):18-21. PubMed ID: 10694292
[TBL] [Abstract][Full Text] [Related]
35. Plasmapheresis as a supplementary treatment in pemphigus.
Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
Arch Immunol Ther Exp (Warsz); 1981; 29(6):763-7. PubMed ID: 7349095
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of bullous pemphigoid by plasma exchange and prednisolone].
Guillaume JC; Roujeau JC; Touzet C; Revuz J; Touraine R
Presse Med; 1985 May; 14(20):1139-42. PubMed ID: 3158980
[TBL] [Abstract][Full Text] [Related]
37. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus.
Czernik A; Beutner EH; Bystryn JC
J Am Acad Dermatol; 2008 May; 58(5):796-801. PubMed ID: 18423257
[TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
40. [The immunocorrective and detoxifying actions of hemosorption, plasmapheresis and enterosorption in pemphigus].
Grebennikov VA; Beliaevskiĭ AD; Kaminskiĭ MIu; Kuzina ZA; Litvinenko TA
Vestn Dermatol Venerol; 1990; (5):33-8. PubMed ID: 2402939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
